PAI Stocktube
StockTube provides investors and traders with cutting edge video interviews from public company executives and active market participants, covering individual companies, foreign exchange, general investment themes and what the city brokers are advising their clients.




Stocktube videos found: 1944 Show results per page:
  • screen_shot_20150417_at_14.12.15.png

    17/04/15

    Red Rock Resources spring cleans its balance sheet

    Red Rock Resources (LON:RRR) has been tidying up its balance sheet by paying off debt and selling its Colombian gold assets. Andrew Bell, the executive chairman tells Proactiveinvestors how the $5 million raised from the sale, in stage payments and royalties, of the El Limon mine to Colombia Mining, will bolster the company’s balance sheet over the coming months. The deal is set to be completed by the end of this month.  The company has also just paid  off some debt to UKBN which Bell believes has put the company in a good position to take advantage of future opportunities.

  • screen_shot_20150417_at_12.39.39.png

    17/04/15

    Caledonia Mining production 'bang on target' for start of 2015

    Mark Learmonth, the CFO of Caledonia Mining, (LON:CMCL) tells Proactiveinvestors that he expects to see increased earnings for 2015 coming through because of their increased focus on cost reduction. Furthermore he expects the tax leakage will be lower because of the level of investment in their mining operation in Zimbabwe. Work has also begun on the sinking he central shaft at its Blanket Mine in Zimbabwe, which will eventually be over 1 kilometre deep. The majority of this work will be funded by future mining cash flows and Learmonth believes, that if the gold price remains stable, the company won't have to dip into its cash pile. Caledonia is due to give a more detailed Q1 update in May.

  • screen_shot_20150417_at_10.33.32.png

    17/04/15

    Challenger Acquisitions Gustafson forsakes oil & gas for Big Wheels

    Challenger Acquisitions (LON:CHAL) Chairman, Mark Gustafson, has spent much of his working life raising finance for oil and gas projects. Now as he  tells Proactiveinvestors, he is shifting his attention to the 'attractions' sector. His recently launched investment vehicle has just signed a co-operation deal with Starneth, the company behind the hugely successful London Eye ferris wheel. The company is also developing new giant observation wheels in Dubai and New York. The agreement  gives Challenger extra reach into a sector which Gustafson describes a “hugely popular”. His ultimate game plan is to become a majority stake in big wheels throughout the world.  “It’s also way more recession-proof than investing resources,” he claims.

  • screen_shot_20150417_at_09.35.13.png

    17/04/15

    CloudTag to release cutting-edge product in wearable tech market

    Amit Ben-Haim, chief executive of CloudTag (LON:CTAG), says that the wearable technology company is on course to start beta trials of a new product with a view to a 2015 release.  Aimed at the wellness and health industry, the company is   targeting the weight loss and weight management market via a heart rate monitor device, apps and the cloud.  Ben-Haim tells Proactive Investors that CloudTag’s scientific achievements and accurate data ‘puts us apart from a lot of companies’ in the wearable technology space. Ben-Haim’s main concern is to deliver a ‘good return’ to shareholders which he has done in the past with many companies.  He says his prime aim it to satisfy shareholders that trusted him, gave him money and the freedom to operate, and he’ll be relentless until he gets the results.  The chief is committed to getting the product to the market and the ‘share price will follow the news.’

  • screen_shot_20150417_at_08.47.43.png

    17/04/15

    Midatech Pharma’s OpsiSporin showing ‘exceedingly good promise’ – CEO

    Jim Phillips, chief executive of Midatech Pharma (LON:MTPH), says eye-disease drug OpsiSporin is on an accelerated programme in terms of investment priorities after it showed ‘exceedingly good promise’ with the company’s controlled release technology.  Philipps tells Proactive Investors that as revenue builds up the specialty pharma company will continue to spend ‘a lot of money’ on research and development to bring products to market. In its full year results Midatech announced  proforma revenues for the combined business which were ‘well ahead of market expectations.’

  • screen_shot_20150416_at_15.36.40.png

    16/04/15

    Mytrah Energy growing rapidly in India on continued access to new capital

    Bob Smith, executive vice president of Mytrah Energy (LON:MYT), says it’s completely focused on India where the renewable energy market is projected to grow to 170 gigawatts over the next five to seven years.  The wind power group has raised US$60mln of new capital in the form of a non-convertible debenture in addition to the recently concluded US$70mln financing. India's Prime Minister Narendra Modi is committed to renewable energy and Smith says 170 gigawatts is ‘like building Germany three times over in terms of its capacity.’

  • screen_shot_20150416_at_110056_2_552f8891bc85a.png

    16/04/15

    Anpario sees 'big opportunities' in the US, China and Brazil

    Richard Edwards, executive vice chairman of  Anpario (LON:ANP), tells Proactive Investors that in addition to the UK, the US, Latin American and Chinese agricultural markets are being targeted for its high performance natural feed additives. The company has just won its first major supply contract with Tyson of the US which is the largest meat producer in the world.  It's also focusing on 10,000 sow farms in China and waiting for an operating licence to be granted in Brazil. Edwards says the company has a very strong balance sheet with approximately £7mln in the bank which it wants to 'invest wisely'.

  • screen_shot_20150416_at_09.27.32.png

    16/04/15

    Motif Bio confident about partner interest in Iclaprim

    Graham Lumsden, chief executive of Motif Bio (LON:MTFB), tells Proactive Investors he is confident about the path forward for Iclaprim. After a 'collaborative meeting' with the FDA, the American regulator gave the biopharmaceutical company the green light to begin phase 111 clinical trials on its next-generation antibiotic. Lumsden is now putting together a strategic business development plan looking at appropriate partners for one or both of the clinical trials to bring in upfront payments and satisfy funding requirements for the trials.

  • screen_shot_20150415_at_14.50.02.png

    15/04/15

    Cohort CEO sees 'good growth opportunities' across all businesses

    Andrew Thomis, chief executive of Cohort (LON:CHRT), tells Proactiveinvestors there is growth potential across all four of the company's subsidiaries. The defence technology group has been awarded a multi-million pound follow-up contract from the MOD, and Thomis says whatever the outcome of this May's General Election "defence will remain an important part of UK expenditure." Cohort aims to grow opportunities in SE Asia where there is 'strong demand' for the company's maritime defence systems, and the Middle East, where Cohort supplies electronic warfare operational support expertise.

  • screen_shot_20150415_at_11.55.20.png

    15/04/15

    Galasys 'excited' about 20% stakeholder Beijing Shiji and Alibaba synergies

    The chairman and chief executive of Galasys (LON:GLS) explain why they are excited about the  company’s maiden full year results since its AIM listing and new 20% stakeholder Beijing Shiji. Chairman Kim Seng Teh and chief executive Sean Seah tell Proactiveinvestors that Shiji’s relationship with China’s online marketplace Alibaba Group presents collaboration opportunities.

1 2 3 4 5 6 7 8 9
  • Wall Street tanks on renewed Greece concerns, new China trading regulations

    Fri 8:53 pm

    Wall Street tanks on renewed Greece concerns, new China trading regulations

    U.S. stocks sank today following a global weakness in equities weighed by renewed Greece concerns and new Chinese trading regulations. The S&P 500 (INDEXSP:.INX) sank 1.1 percent to 2,082 at 3:38 a.m. in New York. The 30-company Dow Jones Industrial Average (INDEXDJX:.DJI) fell 1.4 percent to 17,852, while the tech-heavy Nasdaq Composite (INDEXNASDAQ:.IXIC) surrendered 1.4 percent to 4,933.

  • Argentina focused Madalena increases 2014 production by 165%, adds significant conventional reserves

    Fri 7:07 pm

    Argentina focused Madalena increases 2014 production by 165%, adds significant conventional reserves

    Madalena Energy (CVE:MVN) (OTC:MDLNF), which is an Argentina focused oil and gas energy company, increased its conventional oil and gas reserves on its conventional assets alone by 297% in 2014 through a highly accretive acquisition and successful horizontal drilling in Argentina.

  • TSX retreats with crude price; miners gain

    Fri 5:55 pm

    TSX retreats with crude price; miners gain

    Canadian shares fell for a second day as energy producers weakened on a drop in crude prices, while miners gained as bullion climbed above $1,200 per ounce. The Standard & Poor’s/TSX Composite Index (TSE:OSPTX) fell 0.4 percent to 15,333 at 12:22 p.m. in Toronto. Three shares declined for every two issues that advanced as nine out of ten main share groups were in the negative territory.

  • AmEx reports mixed results hurt by stronger dollar; shares slump

    Fri 2:49 pm

    AmEx reports mixed results hurt by stronger dollar; shares slump

    American Express (NYSE:AXP), a payment-card company, reported higher-than-expected profit rise in the first quarter, but said results were hurt by a stronger dollar. Net income climbed 6.5 percent to $1.53 billion, or $1.48 per share, in the January-to-March quarter, from $1.43 billion, or $1.33 per share, a year earlier, the New York-based company said in a statement late yesterday.